세계의 혈전 관리 기기 시장 규모는 2024년에 18억 5,000만 달러로 평가되었고, 예측 기간 중 CAGR 5.11%로 성장할 전망이며, 2030년에는 24억 7,000만 달러에 달할 것으로 예측되고 있습니다.
세계의 혈전 관리 기기 시장은 심혈관 질환, 심부정맥 혈전증, 뇌졸중의 이환율의 상승에 견인되어 꾸준한 성장을 이루고 있습니다. 이 기기들은 방치하면 생명을 위협하는 상태로 이어지는 혈전의 진단, 예방, 치료에 중요한 역할을 하고 있습니다. 의료 기술의 발전에 따라 저침습 수기의 수요가 높아져 병원과 외래 양쪽에서 혈전 회수 및 흡인 장치의 채용에 박차를 가하고 있습니다. 기계적 혈전 제거 시스템 및 카테터 직접 혈전 용해 요법을 포함한 혈전 관리의 기술 혁신은 임상 회귀를 개선하고 회복 시간을 단축하고 있습니다. 이러한 개발로 인해 특히 시간이 매우 중요한 급성 허혈성 뇌졸중 사례의 표준적 치료가 개선되고 있습니다. 더욱이 인구의 고령화 및 좌식 생활 습관의 증가가 혈전색전증 위험의 상승에 기여하고 있어 시장의 수요를 더욱 끌어올리고 있습니다. 예를 들어 2022년 4월 발표된 논문 '코로나19에서의 심혈관질환 관리'에 따르면 혈전 형성을 포함한 혈액 응고 문제는 전 세계적으로 코로나19 감염과 광범위하게 연관돼 있습니다. 이 바이러스는 혈전색전성 합병증의 위험을 높이는 것으로 나타나고 있으며, 코로나19 환자 치료에 있어 효과적인 혈전 관리의 중요성과 팬데믹 중 관련 심혈관 위험 감소가 강조되고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모(2024년) | 18억 5,000만 달러 |
| 시장 규모(2030년) | 24억 7,000만 달러 |
| CAGR(2025-2030년) | 5.11% |
| 급성장 부문 | 병원 및 클리닉 |
| 최대 시장 | 북미 |
장기적인 합병증 및 의료비의 부담을 줄이기 위해 혈전 관리 기기에 의한 조기 개입의 이점을 인식하는 헬스케어 제공업체가 늘어나고 있습니다. 이 동향은 의료 인프라가 발달한 선진 지역에서 특히 두드러집니다. 한편, 신흥국에서는, 의료 액세스의 개선과 의식의 고조에 의해, 이러한 의료 기기의 도입이 서서히 진행되고 있습니다. 이 시장은 또한 지원적인 상환 정책 및 새로운 혈전 관리 기술의 안전성과 유효성을 검증하는 진행 중인 임상 연구에도 영향을 받고 있습니다. 그러나 기기의 높은 가격, 농촌 지역에서의 접근 제한, 숙련된 전문가의 필요성 등의 과제가 일부 지역에서의 성장을 저해할 수 있습니다. 세계의 혈전 관리 기기 시장은 임상상의 필요성, 기술의 진보, 적극적인 헬스케어 개입에 대한 관심 고조에 힘입어 확대될 것으로 전망되고 있습니다. 시장 개척 기업은 선진국 시장 및 신흥국 시장 양쪽의 헬스케어 시스템에서 환자의 전귀를 개선하고 암메트 메디컬 니즈에 대응하는 혁신적인 솔루션을 제공하기 위해 연구개발에 투자할 것으로 보입니다.
혈전 색전성 질환의 유병률 상승
기기 및 절차의 높은 비용
저침습 치료로 이동
Global Clot Management Devices Market was valued at USD 1.85 billion in 2024 and is expected to reach USD 2.47 billion by 2030 with a CAGR of 5.11% during the forecast period. The global clot management devices market is witnessing steady growth, driven by the rising incidence of cardiovascular diseases, deep vein thrombosis, and stroke. These devices play a crucial role in the diagnosis, prevention, and treatment of blood clots that can lead to life-threatening conditions if left untreated. As medical technology advances, the demand for minimally invasive procedures is increasing, fueling the adoption of clot retrieval and aspiration devices in both hospitals and outpatient settings. Technological innovations in clot management, including mechanical thrombectomy systems and catheter-directed thrombolysis, are enhancing clinical outcomes and reducing recovery times. These developments are improving the standard of care, particularly in acute ischemic stroke cases where time is critical. Furthermore, the aging population and rising prevalence of sedentary lifestyles contribute to a higher risk of thromboembolic disorders, further boosting market demand. For instance, according to the article "Cardiovascular Disease Management in COVID-19," published in April 2022, blood coagulation issues, including clot formation, have been widely associated with COVID-19 infections worldwide. The virus has been shown to increase the risk of thromboembolic complications, highlighting the importance of effective clot management in treating COVID-19 patients and reducing related cardiovascular risks during the pandemic.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.85 Billion |
| Market Size 2030 | USD 2.47 Billion |
| CAGR 2025-2030 | 5.11% |
| Fastest Growing Segment | Hospitals & Clinics |
| Largest Market | North America |
Healthcare providers are increasingly recognizing the benefits of early intervention with clot management devices to reduce the burden of long-term complications and healthcare costs. This trend is particularly evident in developed regions with advanced healthcare infrastructure. Meanwhile, emerging economies are gradually adopting these devices due to improving healthcare access and growing awareness. The market is also influenced by supportive reimbursement policies and ongoing clinical research that validates the safety and efficacy of new clot management technologies. However, challenges such as the high cost of devices, limited access in rural areas, and the need for skilled professionals may hinder growth in some regions. The global clot management devices market is poised for expansion, supported by clinical necessity, technological advancement, and a growing focus on proactive healthcare interventions. Market players are likely to invest in research and development to offer innovative solutions that improve patient outcomes and address unmet medical needs across both developed and developing healthcare systems.
Key Market Drivers
Rising Prevalence of Thromboembolic Disorders
Rising prevalence of thromboembolic disorders is one of the most significant factors propelling the growth of the global clot management devices market. For instance, the World Health Organization (WHO) estimates that by 2050, the global population aged 60 and above will reach 2.1 billion, more than doubling from 1 billion in 2020. This demographic shift highlights the growing need for age-related healthcare solutions, including advanced clot management devices.
Conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic stroke are becoming increasingly common due to lifestyle changes, aging populations, and growing rates of chronic diseases such as obesity, diabetes, and hypertension. These disorders result from the formation of blood clots that obstruct normal blood flow, posing life-threatening risks if not treated promptly. Clot management devices, including thrombectomy systems and catheter-directed thrombolysis tools, are essential for the rapid and effective removal of these clots, helping to prevent complications and reduce mortality. The sedentary nature of modern life, prolonged immobility, and increased incidences of surgical procedures contribute to higher rates of venous thromboembolism. In particular, stroke continues to be a leading cause of death and disability worldwide, placing a significant burden on healthcare systems. With early intervention proving crucial in managing thromboembolic events, hospitals and clinics are increasingly investing in advanced clot management technologies that provide quicker, safer, and more targeted treatment options. Health professionals are recognizing the importance of timely clot removal to avoid permanent damage or fatal outcomes. The growing awareness among patients and clinicians about the risks associated with untreated clots and the benefits of early treatment is leading to increased demand for these devices. This trend underscores the urgency of improving diagnostic capabilities and expanding access to life-saving clot management solutions, especially in high-risk populations.
Key Market Challenges
High Cost of Devices and Procedures
The high cost of devices and procedures is a significant challenge impacting the growth of the global clot management devices market. Advanced clot management systems, such as mechanical thrombectomy devices and catheter-directed thrombolysis tools, often come with substantial price tags. These costs extend beyond the devices themselves and include expenses related to specialized imaging equipment, procedural tools, maintenance, and skilled personnel required to operate them. Hospitals and clinics, particularly in low- and middle-income regions, may struggle to justify these investments given limited healthcare budgets and competing priorities. For patients, high treatment costs can lead to financial strain, especially in areas where health insurance coverage is insufficient or unavailable. Even in developed markets, reimbursement issues can affect both patients and healthcare providers. When coverage is limited or inconsistent, facilities may hesitate to adopt new technologies despite their clinical benefits. This reluctance can delay access to potentially life-saving treatments and contribute to disparities in care across different populations and regions. Cost challenges also impact research and development. Companies aiming to innovate must balance the need for cutting-edge features with the demand for affordability and cost-effectiveness. Striking this balance is complex and can slow down the commercialization of novel technologies. High costs may restrict the use of these devices to well-equipped urban centers, limiting availability in rural or under-resourced areas.
Addressing this challenge requires strategic pricing models, supportive reimbursement policies, and innovations focused on reducing production costs without compromising quality or performance. Lowering economic barriers is essential for expanding access and ensuring broader adoption of clot management technologies.
Key Market Trends
Shift Toward Minimally Invasive Procedures
The shift toward minimally invasive procedures is playing a critical role in driving the growth of the global clot management devices market. Traditional open surgical methods for removing clots often involve greater risk, longer hospital stays, and extended recovery periods. In contrast, minimally invasive techniques, such as catheter-directed thrombolysis and mechanical thrombectomy, offer effective treatment with reduced trauma to the body, faster patient recovery, and shorter hospitalization. These benefits make them increasingly attractive to both healthcare providers and patients. Minimally invasive procedures allow physicians to access and treat clots through small incisions or punctures, often using image-guided tools for precise navigation. This approach significantly reduces complications such as bleeding, infection, and tissue damage, which are more common in open surgeries. As a result, these procedures are being adopted widely in the management of deep vein thrombosis, pulmonary embolism, and ischemic stroke. Healthcare systems are also recognizing the economic advantages of these procedures. Shorter recovery times translate to lower hospital costs, quicker patient turnover, and better resource allocation. In many cases, patients can be treated in outpatient or ambulatory care settings, reducing the burden on hospitals and improving accessibility.
Medical device manufacturers are responding to this trend by developing compact, user-friendly devices that support rapid intervention and high procedural success rates. As patient demand grows for less invasive treatment options, and as medical professionals seek efficient and safe alternatives to surgery, the market for minimally invasive clot management devices is expected to expand significantly in both developed and emerging healthcare settings.
In this report, the Global Clot Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Clot Management Devices Market.
Global Clot Management Devices Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report: